Survival outcomes and prognosis predictors of uveal melanoma from Indian population Article Swipe
Payal Shah
,
Mahesh Shanmugam
,
Neha M Kagathi
,
Annu T Thaliath
,
Sunita Mohan
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.4103/ijo.ijo_350_25
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.4103/ijo.ijo_350_25
Purpose: Choroidal melanoma is an uncommon malignancy in the Asian Indian population, with limited survival data available for this demographic. This study aims to evaluate the survival outcomes and prognostic factors in a cohort of Asian Indian patients with choroidal and ciliochoroidal melanoma. Methods: We conducted a retrospective analysis of 150 patients with choroidal and ciliochoroidal melanoma between 2011 and 2023 at a single tertiary eyecare and ocular oncology center in India. The demographic and clinical profile, using Collaborative Ocular Melanoma Study (COMS) and American Joint Committee on Cancer (AJCC) classification and histopathological features, were recorded. Patients were contacted through various avenues such as telephone, email, and other social media to know their survival status. Kaplan–Meier survival curves and Cox regression were used to determine survival probabilities and prognostic factors. Results: Of the 150 patients, nearly half (48%) of the patients were 50 years or younger at presentation. The melanoma metastasis-related mortality was 16%. The five-year survival was more than 90% in stages T1 and T2, 80% in stage T3, while it dropped to almost 65% in stage T4. The five year disease specific survival (DSS) was 84% (95% CI: 77%–90%), and the 10 year DSS was 66% (95% CI: 53%–77%). Multivariate Cox proportional hazards analysis revealed a significantly increased risk of disease-specific mortality with higher tumor stage, i.e., T2: hazard ratio (HR) = 1.78 (95% confidence interval [CI]: 1.01–3.13; P = 0.045), T3: HR = 4.24 (95% CI: 2.35–7.64; P < 0.001) and T4: HR = 6.38 (95% CI: 3.21–12.67; P < 0.001), compared to T1. Overall, 29 patients developed metastasis during the study period. The five-year metastasis rate was 16% (i.e., 83% of metastasis occurring within first five years), and 10-year metastasis rate was 19.3%. Conclusion: This study highlights favorable survival outcomes in Indian patients with choroidal melanoma, despite a younger age at presentation. The critical window for metastasis management is within the first five years, underscoring the necessity of structured follow-up protocols.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.4103/ijo.ijo_350_25
- OA Status
- diamond
- Cited By
- 1
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412700410
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412700410Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.4103/ijo.ijo_350_25Digital Object Identifier
- Title
-
Survival outcomes and prognosis predictors of uveal melanoma from Indian populationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-28Full publication date if available
- Authors
-
Payal Shah, Mahesh Shanmugam, Neha M Kagathi, Annu T Thaliath, Sunita MohanList of authors in order
- Landing page
-
https://doi.org/10.4103/ijo.ijo_350_25Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.4103/ijo.ijo_350_25Direct OA link when available
- Concepts
-
Medicine, Hazard ratio, Proportional hazards model, Internal medicine, Confidence interval, Stage (stratigraphy), Retrospective cohort study, Survival analysis, Melanoma, Cohort, Population, Oncology, Cancer research, Biology, Environmental health, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412700410 |
|---|---|
| doi | https://doi.org/10.4103/ijo.ijo_350_25 |
| ids.doi | https://doi.org/10.4103/ijo.ijo_350_25 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40719715 |
| ids.openalex | https://openalex.org/W4412700410 |
| fwci | 6.9072928 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000401 |
| mesh[1].descriptor_ui | D008545 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | mortality |
| mesh[1].descriptor_name | Melanoma |
| mesh[2].qualifier_ui | Q000453 |
| mesh[2].descriptor_ui | D008545 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | epidemiology |
| mesh[2].descriptor_name | Melanoma |
| mesh[3].qualifier_ui | Q000175 |
| mesh[3].descriptor_ui | D008545 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | diagnosis |
| mesh[3].descriptor_name | Melanoma |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D008297 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Male |
| mesh[5].qualifier_ui | Q000453 |
| mesh[5].descriptor_ui | D007194 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | epidemiology |
| mesh[5].descriptor_name | India |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005260 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Female |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D012189 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Retrospective Studies |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D008875 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Middle Aged |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D011379 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Prognosis |
| mesh[10].qualifier_ui | Q000401 |
| mesh[10].descriptor_ui | D014604 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | mortality |
| mesh[10].descriptor_name | Uveal Neoplasms |
| mesh[11].qualifier_ui | Q000453 |
| mesh[11].descriptor_ui | D014604 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | epidemiology |
| mesh[11].descriptor_name | Uveal Neoplasms |
| mesh[12].qualifier_ui | Q000175 |
| mesh[12].descriptor_ui | D014604 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | diagnosis |
| mesh[12].descriptor_name | Uveal Neoplasms |
| mesh[13].qualifier_ui | Q000639 |
| mesh[13].descriptor_ui | D015996 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | trends |
| mesh[13].descriptor_name | Survival Rate |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000098943 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Uveal Melanoma |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000328 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Adult |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D005500 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Follow-Up Studies |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D009367 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Neoplasm Staging |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000368 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Aged |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D055815 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Young Adult |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D015994 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Incidence |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | Q000401 |
| mesh[22].descriptor_ui | D008545 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | mortality |
| mesh[22].descriptor_name | Melanoma |
| mesh[23].qualifier_ui | Q000453 |
| mesh[23].descriptor_ui | D008545 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | epidemiology |
| mesh[23].descriptor_name | Melanoma |
| mesh[24].qualifier_ui | Q000175 |
| mesh[24].descriptor_ui | D008545 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | diagnosis |
| mesh[24].descriptor_name | Melanoma |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D008297 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Male |
| mesh[26].qualifier_ui | Q000453 |
| mesh[26].descriptor_ui | D007194 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | epidemiology |
| mesh[26].descriptor_name | India |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D005260 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Female |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D012189 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Retrospective Studies |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D008875 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Middle Aged |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D011379 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Prognosis |
| mesh[31].qualifier_ui | Q000401 |
| mesh[31].descriptor_ui | D014604 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | mortality |
| mesh[31].descriptor_name | Uveal Neoplasms |
| mesh[32].qualifier_ui | Q000453 |
| mesh[32].descriptor_ui | D014604 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | epidemiology |
| mesh[32].descriptor_name | Uveal Neoplasms |
| mesh[33].qualifier_ui | Q000175 |
| mesh[33].descriptor_ui | D014604 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | diagnosis |
| mesh[33].descriptor_name | Uveal Neoplasms |
| mesh[34].qualifier_ui | Q000639 |
| mesh[34].descriptor_ui | D015996 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | trends |
| mesh[34].descriptor_name | Survival Rate |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000098943 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Uveal Melanoma |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000328 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Adult |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D005500 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Follow-Up Studies |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D009367 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Neoplasm Staging |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000368 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Aged |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D055815 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Young Adult |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D015994 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Incidence |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D006801 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Humans |
| mesh[43].qualifier_ui | Q000401 |
| mesh[43].descriptor_ui | D008545 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | mortality |
| mesh[43].descriptor_name | Melanoma |
| mesh[44].qualifier_ui | Q000453 |
| mesh[44].descriptor_ui | D008545 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | epidemiology |
| mesh[44].descriptor_name | Melanoma |
| mesh[45].qualifier_ui | Q000175 |
| mesh[45].descriptor_ui | D008545 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | diagnosis |
| mesh[45].descriptor_name | Melanoma |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008297 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Male |
| mesh[47].qualifier_ui | Q000453 |
| mesh[47].descriptor_ui | D007194 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | epidemiology |
| mesh[47].descriptor_name | India |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D005260 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Female |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D012189 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Retrospective Studies |
| type | article |
| title | Survival outcomes and prognosis predictors of uveal melanoma from Indian population |
| biblio.issue | 8 |
| biblio.volume | 73 |
| biblio.last_page | 1145 |
| biblio.first_page | 1138 |
| topics[0].id | https://openalex.org/T11328 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Ocular Oncology and Treatments |
| topics[1].id | https://openalex.org/T11826 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9947999715805054 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2731 |
| topics[1].subfield.display_name | Ophthalmology |
| topics[1].display_name | Ocular Infections and Treatments |
| topics[2].id | https://openalex.org/T10250 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9896000027656555 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2731 |
| topics[2].subfield.display_name | Ophthalmology |
| topics[2].display_name | Glaucoma and retinal disorders |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9427269697189331 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C207103383 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6691969633102417 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[1].display_name | Hazard ratio |
| concepts[2].id | https://openalex.org/C50382708 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6367306113243103 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q223218 |
| concepts[2].display_name | Proportional hazards model |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5875710844993591 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C44249647 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5280041694641113 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[4].display_name | Confidence interval |
| concepts[5].id | https://openalex.org/C146357865 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5061892867088318 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[5].display_name | Stage (stratigraphy) |
| concepts[6].id | https://openalex.org/C167135981 |
| concepts[6].level | 2 |
| concepts[6].score | 0.500413179397583 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[6].display_name | Retrospective cohort study |
| concepts[7].id | https://openalex.org/C10515644 |
| concepts[7].level | 2 |
| concepts[7].score | 0.47643572092056274 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q543310 |
| concepts[7].display_name | Survival analysis |
| concepts[8].id | https://openalex.org/C2777658100 |
| concepts[8].level | 2 |
| concepts[8].score | 0.47091981768608093 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q180614 |
| concepts[8].display_name | Melanoma |
| concepts[9].id | https://openalex.org/C72563966 |
| concepts[9].level | 2 |
| concepts[9].score | 0.46112769842147827 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[9].display_name | Cohort |
| concepts[10].id | https://openalex.org/C2908647359 |
| concepts[10].level | 2 |
| concepts[10].score | 0.45366910099983215 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[10].display_name | Population |
| concepts[11].id | https://openalex.org/C143998085 |
| concepts[11].level | 1 |
| concepts[11].score | 0.42947307229042053 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[11].display_name | Oncology |
| concepts[12].id | https://openalex.org/C502942594 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[12].display_name | Cancer research |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| concepts[14].id | https://openalex.org/C99454951 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[14].display_name | Environmental health |
| concepts[15].id | https://openalex.org/C151730666 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[15].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9427269697189331 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/hazard-ratio |
| keywords[1].score | 0.6691969633102417 |
| keywords[1].display_name | Hazard ratio |
| keywords[2].id | https://openalex.org/keywords/proportional-hazards-model |
| keywords[2].score | 0.6367306113243103 |
| keywords[2].display_name | Proportional hazards model |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.5875710844993591 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/confidence-interval |
| keywords[4].score | 0.5280041694641113 |
| keywords[4].display_name | Confidence interval |
| keywords[5].id | https://openalex.org/keywords/stage |
| keywords[5].score | 0.5061892867088318 |
| keywords[5].display_name | Stage (stratigraphy) |
| keywords[6].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[6].score | 0.500413179397583 |
| keywords[6].display_name | Retrospective cohort study |
| keywords[7].id | https://openalex.org/keywords/survival-analysis |
| keywords[7].score | 0.47643572092056274 |
| keywords[7].display_name | Survival analysis |
| keywords[8].id | https://openalex.org/keywords/melanoma |
| keywords[8].score | 0.47091981768608093 |
| keywords[8].display_name | Melanoma |
| keywords[9].id | https://openalex.org/keywords/cohort |
| keywords[9].score | 0.46112769842147827 |
| keywords[9].display_name | Cohort |
| keywords[10].id | https://openalex.org/keywords/population |
| keywords[10].score | 0.45366910099983215 |
| keywords[10].display_name | Population |
| keywords[11].id | https://openalex.org/keywords/oncology |
| keywords[11].score | 0.42947307229042053 |
| keywords[11].display_name | Oncology |
| language | en |
| locations[0].id | doi:10.4103/ijo.ijo_350_25 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S191336577 |
| locations[0].source.issn | 0301-4738, 1998-3689 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0301-4738 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Indian Journal of Ophthalmology |
| locations[0].source.host_organization | https://openalex.org/P4310320448 |
| locations[0].source.host_organization_name | Medknow |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320448 |
| locations[0].license | cc-by-nc-sa |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-sa |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Indian Journal of Ophthalmology |
| locations[0].landing_page_url | https://doi.org/10.4103/ijo.ijo_350_25 |
| locations[1].id | pmid:40719715 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Indian journal of ophthalmology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40719715 |
| locations[2].id | pmh:oai:doaj.org/article:cf3badf510c2403a8a2be095b3a2ba27 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Indian Journal of Ophthalmology, Vol 73, Iss 8, Pp 1138-1145 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/cf3badf510c2403a8a2be095b3a2ba27 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5066079417 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-6849-2203 |
| authorships[0].author.display_name | Payal Shah |
| authorships[0].countries | IN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210161759 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[0].institutions[0].id | https://openalex.org/I4210161759 |
| authorships[0].institutions[0].ror | https://ror.org/059aer881 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210161759 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Eye Hospital in Bangalore |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Payal N Shah |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[1].author.id | https://openalex.org/A5061649686 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1912-4412 |
| authorships[1].author.display_name | Mahesh Shanmugam |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210161759 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[1].institutions[0].id | https://openalex.org/I4210161759 |
| authorships[1].institutions[0].ror | https://ror.org/059aer881 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210161759 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Eye Hospital in Bangalore |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mahesh Shanmugam |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[2].author.id | https://openalex.org/A5119094994 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Neha M Kagathi |
| authorships[2].countries | IN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210161759 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[2].institutions[0].id | https://openalex.org/I4210161759 |
| authorships[2].institutions[0].ror | https://ror.org/059aer881 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210161759 |
| authorships[2].institutions[0].country_code | IN |
| authorships[2].institutions[0].display_name | Eye Hospital in Bangalore |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Neha M Kagathi |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[3].author.id | https://openalex.org/A5119094995 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Annu T Thaliath |
| authorships[3].countries | IN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210161759 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[3].institutions[0].id | https://openalex.org/I4210161759 |
| authorships[3].institutions[0].ror | https://ror.org/059aer881 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210161759 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Eye Hospital in Bangalore |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Annu T Thaliath |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[4].author.id | https://openalex.org/A5009600451 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9483-1854 |
| authorships[4].author.display_name | Sunita Mohan |
| authorships[4].countries | IN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210161759 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| authorships[4].institutions[0].id | https://openalex.org/I4210161759 |
| authorships[4].institutions[0].ror | https://ror.org/059aer881 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210161759 |
| authorships[4].institutions[0].country_code | IN |
| authorships[4].institutions[0].display_name | Eye Hospital in Bangalore |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Sunita Mohan |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Vitreoretina and Ocular Oncology, Sankara Eye Hospital, Bengaluru, Karnataka, India |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.4103/ijo.ijo_350_25 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Survival outcomes and prognosis predictors of uveal melanoma from Indian population |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11328 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Ocular Oncology and Treatments |
| related_works | https://openalex.org/W2994686985, https://openalex.org/W2797301068, https://openalex.org/W2010631330, https://openalex.org/W2006470775, https://openalex.org/W2581226876, https://openalex.org/W4225134093, https://openalex.org/W4380269519, https://openalex.org/W3136232645, https://openalex.org/W4380448775, https://openalex.org/W1554732404 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.4103/ijo.ijo_350_25 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S191336577 |
| best_oa_location.source.issn | 0301-4738, 1998-3689 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0301-4738 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Indian Journal of Ophthalmology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320448 |
| best_oa_location.source.host_organization_name | Medknow |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320448 |
| best_oa_location.license | cc-by-nc-sa |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-sa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Indian Journal of Ophthalmology |
| best_oa_location.landing_page_url | https://doi.org/10.4103/ijo.ijo_350_25 |
| primary_location.id | doi:10.4103/ijo.ijo_350_25 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S191336577 |
| primary_location.source.issn | 0301-4738, 1998-3689 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0301-4738 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Indian Journal of Ophthalmology |
| primary_location.source.host_organization | https://openalex.org/P4310320448 |
| primary_location.source.host_organization_name | Medknow |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320448 |
| primary_location.license | cc-by-nc-sa |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-sa |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Indian Journal of Ophthalmology |
| primary_location.landing_page_url | https://doi.org/10.4103/ijo.ijo_350_25 |
| publication_date | 2025-07-28 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3129017423, https://openalex.org/W6790257341, https://openalex.org/W2143878396, https://openalex.org/W2122979626, https://openalex.org/W6677918358, https://openalex.org/W2046862003, https://openalex.org/W2024283519, https://openalex.org/W6656811929, https://openalex.org/W2166771927, https://openalex.org/W2089223199, https://openalex.org/W6672942418, https://openalex.org/W2055835855, https://openalex.org/W4214643770, https://openalex.org/W3090017828, https://openalex.org/W4292290939, https://openalex.org/W2559379131, https://openalex.org/W2280714165, https://openalex.org/W3037447311, https://openalex.org/W2755055488, https://openalex.org/W2884043954, https://openalex.org/W4400972548, https://openalex.org/W2016284281, https://openalex.org/W4238749013, https://openalex.org/W2076264745, https://openalex.org/W1977781331, https://openalex.org/W2036513065, https://openalex.org/W2602760334, https://openalex.org/W2913612771, https://openalex.org/W33364968, https://openalex.org/W2099220064, https://openalex.org/W3041130918, https://openalex.org/W4382986841, https://openalex.org/W2991072085, https://openalex.org/W4383483641, https://openalex.org/W3120109103 |
| referenced_works_count | 35 |
| abstract_inverted_index.= | 223, 231, 235, 246 |
| abstract_inverted_index.P | 230, 240, 251 |
| abstract_inverted_index.a | 32, 46, 62, 207, 301 |
| abstract_inverted_index.10 | 193 |
| abstract_inverted_index.29 | 258 |
| abstract_inverted_index.50 | 142 |
| abstract_inverted_index.HR | 234, 245 |
| abstract_inverted_index.Of | 131 |
| abstract_inverted_index.T1 | 163 |
| abstract_inverted_index.We | 44 |
| abstract_inverted_index.an | 4 |
| abstract_inverted_index.as | 103 |
| abstract_inverted_index.at | 61, 146, 304 |
| abstract_inverted_index.in | 7, 31, 70, 161, 167, 176, 294 |
| abstract_inverted_index.is | 3, 312 |
| abstract_inverted_index.it | 171 |
| abstract_inverted_index.of | 34, 49, 138, 211, 274, 321 |
| abstract_inverted_index.on | 87 |
| abstract_inverted_index.or | 144 |
| abstract_inverted_index.to | 23, 110, 123, 173, 255 |
| abstract_inverted_index.150 | 50, 133 |
| abstract_inverted_index.16% | 271 |
| abstract_inverted_index.65% | 175 |
| abstract_inverted_index.66% | 197 |
| abstract_inverted_index.80% | 166 |
| abstract_inverted_index.83% | 273 |
| abstract_inverted_index.84% | 187 |
| abstract_inverted_index.90% | 160 |
| abstract_inverted_index.CI: | 189, 199, 238, 249 |
| abstract_inverted_index.Cox | 119, 202 |
| abstract_inverted_index.DSS | 195 |
| abstract_inverted_index.T1. | 256 |
| abstract_inverted_index.T2, | 165 |
| abstract_inverted_index.T2: | 219 |
| abstract_inverted_index.T3, | 169 |
| abstract_inverted_index.T3: | 233 |
| abstract_inverted_index.T4. | 178 |
| abstract_inverted_index.T4: | 244 |
| abstract_inverted_index.The | 72, 148, 154, 179, 266, 306 |
| abstract_inverted_index.age | 303 |
| abstract_inverted_index.and | 28, 40, 54, 59, 66, 74, 83, 91, 106, 118, 127, 164, 191, 243, 281 |
| abstract_inverted_index.for | 17, 309 |
| abstract_inverted_index.the | 8, 25, 132, 139, 192, 263, 314, 319 |
| abstract_inverted_index.was | 152, 157, 186, 196, 270, 285 |
| abstract_inverted_index.< | 241, 252 |
| abstract_inverted_index.(95% | 188, 198, 225, 237, 248 |
| abstract_inverted_index.(HR) | 222 |
| abstract_inverted_index.1.78 | 224 |
| abstract_inverted_index.16%. | 153 |
| abstract_inverted_index.2011 | 58 |
| abstract_inverted_index.2023 | 60 |
| abstract_inverted_index.4.24 | 236 |
| abstract_inverted_index.6.38 | 247 |
| abstract_inverted_index.This | 20, 288 |
| abstract_inverted_index.aims | 22 |
| abstract_inverted_index.data | 15 |
| abstract_inverted_index.five | 180, 279, 316 |
| abstract_inverted_index.half | 136 |
| abstract_inverted_index.know | 111 |
| abstract_inverted_index.more | 158 |
| abstract_inverted_index.rate | 269, 284 |
| abstract_inverted_index.risk | 210 |
| abstract_inverted_index.such | 102 |
| abstract_inverted_index.than | 159 |
| abstract_inverted_index.this | 18 |
| abstract_inverted_index.used | 122 |
| abstract_inverted_index.were | 94, 97, 121, 141 |
| abstract_inverted_index.with | 12, 38, 52, 214, 297 |
| abstract_inverted_index.year | 181, 194 |
| abstract_inverted_index.(48%) | 137 |
| abstract_inverted_index.(DSS) | 185 |
| abstract_inverted_index.Asian | 9, 35 |
| abstract_inverted_index.Joint | 85 |
| abstract_inverted_index.Study | 81 |
| abstract_inverted_index.[CI]: | 228 |
| abstract_inverted_index.first | 278, 315 |
| abstract_inverted_index.i.e., | 218 |
| abstract_inverted_index.media | 109 |
| abstract_inverted_index.other | 107 |
| abstract_inverted_index.ratio | 221 |
| abstract_inverted_index.stage | 168, 177 |
| abstract_inverted_index.study | 21, 264, 289 |
| abstract_inverted_index.their | 112 |
| abstract_inverted_index.tumor | 216 |
| abstract_inverted_index.using | 77 |
| abstract_inverted_index.while | 170 |
| abstract_inverted_index.years | 143 |
| abstract_inverted_index.(AJCC) | 89 |
| abstract_inverted_index.(COMS) | 82 |
| abstract_inverted_index.(i.e., | 272 |
| abstract_inverted_index.0.001) | 242 |
| abstract_inverted_index.19.3%. | 286 |
| abstract_inverted_index.Cancer | 88 |
| abstract_inverted_index.India. | 71 |
| abstract_inverted_index.Indian | 10, 36, 295 |
| abstract_inverted_index.Ocular | 79 |
| abstract_inverted_index.almost | 174 |
| abstract_inverted_index.center | 69 |
| abstract_inverted_index.cohort | 33 |
| abstract_inverted_index.curves | 117 |
| abstract_inverted_index.during | 262 |
| abstract_inverted_index.email, | 105 |
| abstract_inverted_index.hazard | 220 |
| abstract_inverted_index.higher | 215 |
| abstract_inverted_index.nearly | 135 |
| abstract_inverted_index.ocular | 67 |
| abstract_inverted_index.single | 63 |
| abstract_inverted_index.social | 108 |
| abstract_inverted_index.stage, | 217 |
| abstract_inverted_index.stages | 162 |
| abstract_inverted_index.window | 308 |
| abstract_inverted_index.within | 277, 313 |
| abstract_inverted_index.years, | 317 |
| abstract_inverted_index.0.001), | 253 |
| abstract_inverted_index.0.045), | 232 |
| abstract_inverted_index.10-year | 282 |
| abstract_inverted_index.avenues | 101 |
| abstract_inverted_index.between | 57 |
| abstract_inverted_index.despite | 300 |
| abstract_inverted_index.disease | 182 |
| abstract_inverted_index.dropped | 172 |
| abstract_inverted_index.eyecare | 65 |
| abstract_inverted_index.factors | 30 |
| abstract_inverted_index.hazards | 204 |
| abstract_inverted_index.limited | 13 |
| abstract_inverted_index.period. | 265 |
| abstract_inverted_index.status. | 114 |
| abstract_inverted_index.through | 99 |
| abstract_inverted_index.various | 100 |
| abstract_inverted_index.years), | 280 |
| abstract_inverted_index.younger | 145, 302 |
| abstract_inverted_index.American | 84 |
| abstract_inverted_index.Melanoma | 80 |
| abstract_inverted_index.Methods: | 43 |
| abstract_inverted_index.Overall, | 257 |
| abstract_inverted_index.Patients | 96 |
| abstract_inverted_index.Purpose: | 0 |
| abstract_inverted_index.Results: | 130 |
| abstract_inverted_index.analysis | 48, 205 |
| abstract_inverted_index.clinical | 75 |
| abstract_inverted_index.compared | 254 |
| abstract_inverted_index.critical | 307 |
| abstract_inverted_index.evaluate | 24 |
| abstract_inverted_index.factors. | 129 |
| abstract_inverted_index.interval | 227 |
| abstract_inverted_index.melanoma | 2, 56, 149 |
| abstract_inverted_index.oncology | 68 |
| abstract_inverted_index.outcomes | 27, 293 |
| abstract_inverted_index.patients | 37, 51, 140, 259, 296 |
| abstract_inverted_index.profile, | 76 |
| abstract_inverted_index.revealed | 206 |
| abstract_inverted_index.specific | 183 |
| abstract_inverted_index.survival | 14, 26, 113, 116, 125, 156, 184, 292 |
| abstract_inverted_index.tertiary | 64 |
| abstract_inverted_index.uncommon | 5 |
| abstract_inverted_index.Choroidal | 1 |
| abstract_inverted_index.Committee | 86 |
| abstract_inverted_index.available | 16 |
| abstract_inverted_index.choroidal | 39, 53, 298 |
| abstract_inverted_index.conducted | 45 |
| abstract_inverted_index.contacted | 98 |
| abstract_inverted_index.determine | 124 |
| abstract_inverted_index.developed | 260 |
| abstract_inverted_index.favorable | 291 |
| abstract_inverted_index.features, | 93 |
| abstract_inverted_index.five-year | 155, 267 |
| abstract_inverted_index.follow-up | 323 |
| abstract_inverted_index.increased | 209 |
| abstract_inverted_index.melanoma, | 299 |
| abstract_inverted_index.melanoma. | 42 |
| abstract_inverted_index.mortality | 151, 213 |
| abstract_inverted_index.necessity | 320 |
| abstract_inverted_index.occurring | 276 |
| abstract_inverted_index.patients, | 134 |
| abstract_inverted_index.recorded. | 95 |
| abstract_inverted_index.confidence | 226 |
| abstract_inverted_index.highlights | 290 |
| abstract_inverted_index.malignancy | 6 |
| abstract_inverted_index.management | 311 |
| abstract_inverted_index.metastasis | 261, 268, 275, 283, 310 |
| abstract_inverted_index.prognostic | 29, 128 |
| abstract_inverted_index.protocols. | 324 |
| abstract_inverted_index.regression | 120 |
| abstract_inverted_index.structured | 322 |
| abstract_inverted_index.telephone, | 104 |
| abstract_inverted_index.53%–77%). | 200 |
| abstract_inverted_index.77%–90%), | 190 |
| abstract_inverted_index.Conclusion: | 287 |
| abstract_inverted_index.demographic | 73 |
| abstract_inverted_index.population, | 11 |
| abstract_inverted_index.1.01–3.13; | 229 |
| abstract_inverted_index.2.35–7.64; | 239 |
| abstract_inverted_index.Multivariate | 201 |
| abstract_inverted_index.demographic. | 19 |
| abstract_inverted_index.proportional | 203 |
| abstract_inverted_index.underscoring | 318 |
| abstract_inverted_index.3.21–12.67; | 250 |
| abstract_inverted_index.Collaborative | 78 |
| abstract_inverted_index.presentation. | 147, 305 |
| abstract_inverted_index.probabilities | 126 |
| abstract_inverted_index.retrospective | 47 |
| abstract_inverted_index.significantly | 208 |
| abstract_inverted_index.Kaplan–Meier | 115 |
| abstract_inverted_index.ciliochoroidal | 41, 55 |
| abstract_inverted_index.classification | 90 |
| abstract_inverted_index.disease-specific | 212 |
| abstract_inverted_index.histopathological | 92 |
| abstract_inverted_index.metastasis-related | 150 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5061649686 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| corresponding_institution_ids | https://openalex.org/I4210161759 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.92769109 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |